The role of peptides in bone healing and regeneration: A systematic review

Background: Bone tissue engineering and the research surrounding peptides has expanded significantly over the last few decades. Several peptides have been shown to support and stimulate the bone healing response and have been proposed as therapeutic vehicles for clinical use. The aim of this comprehensive review is to present the clinical and experimental studies analysing the potential role of peptides for bone healing and bone regeneration. Methods: A systematic review according to PRISMA guidelines was conducted. Articles presenting peptides capable of exerting an upregulatory effect on osteoprogenitor cells and bone healing were included in the study. Results: Based on the available literature, a significant amount of experimental in vitro and in vivo evidence exists. Several peptides were found to upregulate the bone healing response in experimental models and could act as potential candidates for future clinical applications. However, from the available peptides that reached the level of clinical trials, the presented results are limited. Conclusion: Further research is desirable to shed more light into the processes governing the osteoprogenitor cellular responses. With further advances in the field of biomimetic materials and scaffolds, new treatment modalities for bone repair will emerge

The integration of mutant loci affecting maize endosperm development in a dense genetic map using an AFLP-based procedure

In this paper, 10 mutations conditioning the appearance of defective, miniature or collapsed endosperm, but with normal sporophyte development, were considered. Homozygous mutant kernels have reduced grain weight, kernel size, density and, in some of these, higher than normal seed protein content. The mutant loci were integrated into a highresolution genetic map in order to associate them to specific genes. We have placed 1167 AFLP markers on a consensus map using IBM2 as a backbone and reaching an average of 1 marker every 1.9 cM. We have identified AFLP markers linked to all individual mutant alleles. BSA was adopted to screen the largest possible number of primer combinations on homozygous F3 mutant and wild type plants. The ten mutant loci are linked to the closest AFLP or SSR markers with distances ranging from 0 to 17.9 cM. The genes we have defined by the existence of mendelian mutants can now be considered good candidates for testing the association to QT loci

ATOSIBAN VS RITODRINE USED PROPHYLACTICALLY WITH CERCLAGE IN ICSI PREGNANCIES TO PREVENT PRE-TERM BIRTH IN WOMEN IDENTIFIED AS BEING AT HIGH RISK ON THE BASIS OF TRANSVAGINAL ULTRASOUND SCAN

Our objective was to compare the effectiveness and safety of atosiban and ritodrine, in pregnancies obtained by intracytoplasmic sperm injection (ICSI) undergoing cervical cerclage. Data from a prospective study were compared with those from a retrospective study. Sixteen ICSI pregnant women, 20-24 weeks' gestation and maternal age >18 years, received atosiban (bolus dose 6.75 mg i.v., followed by 300 microg/min i.v. for 3 h and 100 microg/min i.v. for 45 h). Cervical cerclage was performed 3 h after starting atosiban. The control group (group B) of 16 ICSI pregnant women were matched and received ritodrine hydrochloride (100-350 microg/min) for 48 h. Cervical cerclage was performed after 24 h. Pre-term rupture of membranes occurred within 48 h of cervical cerclage in one woman receiving atosiban and in four women receiving ritodrine. There was no significant difference in terms of pregnancies not delivered at 48 h (short-term tocolysis) and at 7 days (long-term tocolysis). However, there was a significantly higher incidence of maternal tachycardia with ritodrine compared with atosiban (p < 0.001). The mean gestational age at delivery was significantly higher for atosiban compared with ritodrine (36 vs 33 weeks; p < 0.001). The neonatal outcome was poorer for ritodrine than atosiban, as there were very low birth weight infants (p = 0.008), resulting in lower Apgar scores (p = 0.005) and there were more neonates requiring a long stay in the neonatal intensive care unit (p = 0.005). We conclude that atosiban is associated with a significantly lower incidence of maternal tachycardia and improved neonatal outcome compared with ritodrine

Sexual Health After Acute Myocardial Infarction: The Lived Experience of Women During the First-Year Post Discharge

The quality of life (QOL) for patients who have survived an acute myocardial infarction (AMI) depends on their perceptions of their sex lives. Although all educational-rehabilitative international guidelines recommend that this issue would be considered, healthcare professionals and patients who have suffered from AMIs rarely give it the attention it requires. Resuming normal sexual activity after a myocardial infarction can improve QOL by reducing anxiety, stress, and depression. This study aims to develop an understanding of the sexual health experiences of Italian women 1 year after they experienced AMIs. This qualitative study used Cohen’s phenomenological design. A sample of 12 women was interviewed. Each interview was audio-recorded, and all interviews had a duration ranging from 40 to 60 min. Interviews were read, re-read, and analyzed by each researcher, who then extrapolated themes. Three main themes emerged from the analysis of the interviews: the fear of a recurring infarction, stress, and the desire to receive information about their recovery. Two sub-themes also emerged: changes in their sexual lives and difficult relationships with their partners. For patients who have survived myocardial infarctions, sexuality is an important aspect of their health and QOL. Understanding these experiences in women who have suffered from AMIs can facilitate deeper reflection in healthcare providers and enable them to create targeted rehabilitation and psychological programs